Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Arzneimittelwerk describes novel antiepileptic agents

April 11, 1997

Astra prepares NOS inhibitors

April 11, 1997

Selective 5-HT1Dalpha receptor agonists from MS&D

April 11, 1997

Pharmacia & Upjohn discontinues roquinimex MS trials

April 10, 1997

New carbamate derivative from Kyorin with high affinity/selectivity for M1 receptors

April 10, 1997

New bradykinin B2 antagonist from Fujisawa

April 10, 1997

Pharmacia & Upjohn describes compounds for amyloidosis

April 10, 1997

NMDA antagonist revealed by Sumitomo

April 10, 1997

Selfadministration device for Imitrex available in the U.S.

April 9, 1997

Agents for cerebral ischemia and neurodegenerative disorders from Boehringer Ingelheim

April 9, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...